Human leucocyte antigen-A2 increases risk of Alzheimer's disease but does not affect age of onset in a Scottish population

J M Harris, A M Cumming, N Craddock, D St Clair, C L Lendon

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The use of non-steroidal anti-inflammatory drugs has been associated with a reduced incidence of Alzheimer's disease (AD), suggesting that attenuation of the inflammatory response may be beneficial. Several, but not all, genetic association studies have shown human leucocyte antigen (HLA)-A2, a major histocompatibility complex class I antigen-binding transmembrane protein has an increased frequency in AD compared to controls, and in some reports is associated with a lowered age of onset. We further investigated the role of HLA-A2 in an independent sample of AD cases, including a large early onset cohort. The results of this current study and meta analysis of all studies available to date support previous evidence of an excess of HLA-A2 in AD, but found no evidence of a relationship with age of onset. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)37-40
Number of pages4
JournalNeuroscience Letters
Volume294
Publication statusPublished - 2000

Keywords

  • Alzheimer's disease
  • apolipoprotein E
  • human leucocyte antigen
  • HISTOCOMPATIBILITY ANTIGENS
  • HLA-A2 ALLELE
  • APOLIPOPROTEIN-E
  • ASSOCIATION
  • SUSCEPTIBILITY
  • GENE
  • POLYMORPHISM
  • MEN

Cite this

Human leucocyte antigen-A2 increases risk of Alzheimer's disease but does not affect age of onset in a Scottish population. / Harris, J M ; Cumming, A M ; Craddock, N ; St Clair, D ; Lendon, C L .

In: Neuroscience Letters, Vol. 294, 2000, p. 37-40.

Research output: Contribution to journalArticle

@article{6ead80a086b346e8acca1929262a60b8,
title = "Human leucocyte antigen-A2 increases risk of Alzheimer's disease but does not affect age of onset in a Scottish population",
abstract = "The use of non-steroidal anti-inflammatory drugs has been associated with a reduced incidence of Alzheimer's disease (AD), suggesting that attenuation of the inflammatory response may be beneficial. Several, but not all, genetic association studies have shown human leucocyte antigen (HLA)-A2, a major histocompatibility complex class I antigen-binding transmembrane protein has an increased frequency in AD compared to controls, and in some reports is associated with a lowered age of onset. We further investigated the role of HLA-A2 in an independent sample of AD cases, including a large early onset cohort. The results of this current study and meta analysis of all studies available to date support previous evidence of an excess of HLA-A2 in AD, but found no evidence of a relationship with age of onset. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.",
keywords = "Alzheimer's disease, apolipoprotein E, human leucocyte antigen, HISTOCOMPATIBILITY ANTIGENS, HLA-A2 ALLELE, APOLIPOPROTEIN-E, ASSOCIATION, SUSCEPTIBILITY, GENE, POLYMORPHISM, MEN",
author = "Harris, {J M} and Cumming, {A M} and N Craddock and {St Clair}, D and Lendon, {C L}",
year = "2000",
language = "English",
volume = "294",
pages = "37--40",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Human leucocyte antigen-A2 increases risk of Alzheimer's disease but does not affect age of onset in a Scottish population

AU - Harris, J M

AU - Cumming, A M

AU - Craddock, N

AU - St Clair, D

AU - Lendon, C L

PY - 2000

Y1 - 2000

N2 - The use of non-steroidal anti-inflammatory drugs has been associated with a reduced incidence of Alzheimer's disease (AD), suggesting that attenuation of the inflammatory response may be beneficial. Several, but not all, genetic association studies have shown human leucocyte antigen (HLA)-A2, a major histocompatibility complex class I antigen-binding transmembrane protein has an increased frequency in AD compared to controls, and in some reports is associated with a lowered age of onset. We further investigated the role of HLA-A2 in an independent sample of AD cases, including a large early onset cohort. The results of this current study and meta analysis of all studies available to date support previous evidence of an excess of HLA-A2 in AD, but found no evidence of a relationship with age of onset. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.

AB - The use of non-steroidal anti-inflammatory drugs has been associated with a reduced incidence of Alzheimer's disease (AD), suggesting that attenuation of the inflammatory response may be beneficial. Several, but not all, genetic association studies have shown human leucocyte antigen (HLA)-A2, a major histocompatibility complex class I antigen-binding transmembrane protein has an increased frequency in AD compared to controls, and in some reports is associated with a lowered age of onset. We further investigated the role of HLA-A2 in an independent sample of AD cases, including a large early onset cohort. The results of this current study and meta analysis of all studies available to date support previous evidence of an excess of HLA-A2 in AD, but found no evidence of a relationship with age of onset. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.

KW - Alzheimer's disease

KW - apolipoprotein E

KW - human leucocyte antigen

KW - HISTOCOMPATIBILITY ANTIGENS

KW - HLA-A2 ALLELE

KW - APOLIPOPROTEIN-E

KW - ASSOCIATION

KW - SUSCEPTIBILITY

KW - GENE

KW - POLYMORPHISM

KW - MEN

M3 - Article

VL - 294

SP - 37

EP - 40

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

ER -